ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,900Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 25

$1.14M Total Retail Price of All Prescriptions

Rank: 1 out of 25

508 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 15,492 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 35%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 931 777 1 1
AMLODIPINE BESYLATE 800 697 2 2
FUROSEMIDE 631 533 3 3
OMEPRAZOLE 539 441 4 6
METOPROLOL TARTRATE 430 380 5 8
METOPROLOL SUCCINATE 392 325 6 9
DONEPEZIL HCL 354 347 7 21
ATORVASTATIN CALCIUM 339 309 8 4
TRAMADOL HCL 299 234 9 25
ENALAPRIL MALEATE 293 246 10 26
CARVEDILOL 260 223 11 16
METFORMIN HCL 249 205 12 10
CLOPIDOGREL 245 208 13 19
DIOVAN HCT 235 185 14 20
WARFARIN SODIUM 234 225 15 12
POTASSIUM CHLORIDE 234 168 15 29
LEVOTHYROXINE SODIUM 209 192 17 5
ZOLPIDEM TARTRATE 207 139 18 13
NAMENDA 205 205 19 32
PRANDIN 201 166 20 69
DIOVAN 194 175 21 14
SINGULAIR 190 153 22 60
FAMOTIDINE 168 139 23 56
LOSARTAN-HYDROCHLOROTHIAZIDE 167 129 24 45
OXYCODONE-ACETAMINOPHEN 167 147 S2 24 52
LACTULOSE 157 152 26 55
GABAPENTIN 157 102 26 37
HYDRALAZINE HCL 153 130 28 81
GLIPIZIDE 153 133 28 42
LISINOPRIL 149 121 30 7
CLONIDINE HCL 147 103 31 58
BACLOFEN 145 94 32 86
PLAVIX 143 120 33 51
AMLODIPINE BESYLATE-BENAZEPRIL 141 137 34 31
ACETAMINOPHEN-CODEINE 140 115 S3 35 90
GLYBURIDE-METFORMIN HCL 134 94 R 36 65
NITROGLYCERIN PATCH 134 133 36 93
PROAIR HFA 133 78 38 44
RISPERIDONE 132 105 39 50
CRESTOR 132 99 39 11
BUMETANIDE 125 118 41 94
GLIMEPIRIDE 122 118 42 28
ESCITALOPRAM OXALATE 121 111 43 38
HYDROCHLOROTHIAZIDE 117 109 44 18
PHENYTOIN SODIUM EXTENDED 111 85 45 74
RAMIPRIL 111 106 45 30
TAMSULOSIN HCL 110 100 47 17
ALENDRONATE SODIUM 104 96 48 23
NEXIUM 103 88 49 15
LIDODERM 102 75 50 106
MONTELUKAST SODIUM 100 76 51 108
LOSARTAN POTASSIUM 100 80 51 24
MIRTAZAPINE 97 91 53 33
LYRICA 97 82 53 84
PANTOPRAZOLE SODIUM 93 60 55 43
ENDOCET 93 39 S2 55 67
ADVAIR DISKUS 90 72 57 27
OXYCODONE HCL 88 36 S2 58 39
CIPROFLOXACIN HCL 88 62 58 68
ONGLYZA 87 64 60 110
ISOSORBIDE MONONITRATE ER 85 76 61 57
IBUPROFEN 84 29 62 112
NOVOLOG FLEXPEN 84 71 62 112
LANTUS 80 63 64 53
TRICOR 78 62 65 79
NIFEDIPINE ER 76 64 66 88
GLIPIZIDE XL 75 75 67 82
JANUVIA 74 70 68 35
MELOXICAM 73 62 69 41
SERTRALINE HCL 71 70 70 36
CILOSTAZOL 71 70 70 121
CELEBREX 70 64 72 70
LEVOFLOXACIN 69 58 73 92
PROMETHAZINE VC 68 48 R 74 126
NOVOLOG 64 57 75 73
LIPITOR 64 61 75 47
JANUMET 64 45 75 129
METOCLOPRAMIDE HCL 63 53 78 131
GLIPIZIDE ER 60 60 79 136
BENAZEPRIL HCL 59 42 80 137
LANTUS SOLOSTAR 59 47 80 96
FENTANYL 57 57 S2 82 102
DESOXIMETASONE 56 44 83 144
TRIAMTERENE-HCTZ 55 43 84 76
DIGOXIN 55 45 84 61
VENTOLIN HFA 53 25 86 82
MUPIROCIN 52 43 87 148
VALSARTAN-HYDROCHLOROTHIAZIDE 52 45 87 148
TRAVATAN Z 51 51 89 152
PREDNISONE 50 37 90 54
LEVEMIR FLEXPEN 50 46 90 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.